Patrick Treanor - 26 May 2022 Form 3 Insider Report for KalVista Pharmaceuticals, Inc. (KALV)

Role
Director
Signature
/s/ Benjamin L. Palleiko, Attorney-in-Fact
Issuer symbol
KALV
Transactions as of
26 May 2022
Net transactions value
$0
Form type
3
Filing time
27 May 2022, 16:16:43 UTC
Next filing
28 Sep 2023

No securities are beneficially owned.

Remarks:

No securities are beneficially owned.